We've found
18,515
archived clinical trials in
Lymphoma
We've found
18,515
archived clinical trials in
Lymphoma
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Updated: 1/1/1970
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Updated: 1/1/1970
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Updated: 1/1/1970
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Updated: 1/1/1970
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Updated: 1/1/1970
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Updated: 1/1/1970
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Updated: 1/1/1970
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Updated: 1/1/1970
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Updated: 1/1/1970
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Updated: 1/1/1970
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Updated: 1/1/1970
A Phase 1b, Multicenter, Open-label, Parallel-group Safety Study of a Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI 32765, in Combination With Chemotherapy in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Archived
Updated: 1/1/1970
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
A Phase I/II Study of Intratumoral Injection of the Small Molecule TLR8 Agonist VTX-2337 in Combination With Local Radiation in Low-Grade B-cell Lymphomas
Status: Archived
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
Updated: 1/1/1970
A Phase I/II Study of Intratumoral Injection of the Small Molecule TLR8 Agonist VTX-2337 in Combination With Local Radiation in Low-Grade B-cell Lymphomas
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Updated: 1/1/1970
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
Status: Archived
Updated: 1/1/1970